Pharmacokinetics and tissue distribution of liposomal etoposide in rats

Drug Delivery

Volumn 16, Issue 8, 2009, Pages 423-429

  Sistla, Anand ^a,b   Smith, David J ^c   Kobrinsky, Nathan L ^d   Kumar, Krishna ^a,e  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

^b PFIZER INC   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

^d MeritCare Roger Maris Cancer Center   (United States)

^e HOWARD UNIVERSITY   (United States)

Author keywords

Charges; Etoposide; Liposomes; Pharmacokinetics; Tissue distribution

Indexed keywords

ETOPOSIDE; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG UPTAKE; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; DRUG STABILITY; ETOPOSIDE; INJECTIONS, INTRAVENOUS; LIPOSOMES; MALE; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 70350307006     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717540903223418     Document Type: Article

References (31)

1. Abra, R.M., Hunt, C.A. (1981). Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim Biophys Acta. 666, 493-503.
2. Abra, R.M., Hunt, C.A., Lau, D.T. (1984). Liposome disposition in vivo. VI: delivery to the lung. J Pharml Sci. 73, 203-2066.
3. Allen, T.M., Cleland, L.G. (1980). Serum-induced leakage of liposome contents. Biochim Biophys Acta. 597, 418-426
4. Benet, L.Z., Kroetz, D.L., Sheiner, L.B. (1996). Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: Goodman and Gilman's The pharmacological basis of therapeutics. eds. Hardman, J.G., Limbird, L.E., Gilman, A.G. 9th Ed. New York: McGraw Hill, 3-27.
5. Brandl, M. (2001). Liposomes as drug carriers: a technological approach. Biotechnol Annu Rev. 7, 59-85.
6. Burgio D.E., Gosland, M.P., McNamara, P.J. (1996). Modulation effects of cyclosporine on etoposide pharmacokinetics and CNS distribution in the rat utilizing microdialysis. Biochem Pharmacol. 51, 987-992
7. Figueroa, M., Gehlsen, J., Hammond, D., Ondreyco, S., Piro, L., Palmary, T., Williams, F., McMillan, R. (1993). Combination chemotherapy in refractory immune thrombocytopenic purpura. N Engl J Med. 328, 1226-1229
8. Fleming, R.A., Stewart, F.C. (1991). High performance liquid chromatographic determination of etoposide in plasma. J Liq Chromatog. 14, 1275-1283
9. Gabrielsson, J., Weiner, D. (1994). Pharmacokinetic and pharmacodynamic data analysis. Concepts and applications. Stockholm, Sweden: Swedish Pharmaceutical Press, 13.
10. Gadner, H., Grois, N., Arico, M., Broadbent, V., Ceci, A., Jakobson, A., Komp, D., Michaelis, J.N., Nicholson, S., Potschger, U., Pritchard, J., Ladisch, S. (2001). A randomized trial for treatement of multisystem Langerhans' cell histiocytosis. J Pediat. 138, 728-734
11. Gibaldi, M., Perrier, D. (1982). Pharmacokinetics. Vol I. New York: Marcel Dekker Inc.
12. Gregoriadis G. (1995). Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol 13, 527-537
13. Hande K.R. (1998). Etoposide: four decades of development of a topoisomerase II Inhibitor. Eur J Cancer. 34, 1514-1521
14. Hande, K., Bennett, R., Hamilton, R., Grote, T., Branch, R. (1988). Metabolism and excretion of etoposide in isolated, perfused rat liver models. Cancer Res. 48, 5692-5695 (Pubitemid 18248127)
15. Hatta, Y., Takahashi, M., Enomoto, Y., Takahashi, N., Sawada, U., Horie, T. (2004). Adenosine phosphate (ATP) enhances the antitumor effect of etoposide (VP-16) in lung cancer. Oncol Rep. 12, 1139-1142
16. Herzog, T.J. (2004). Recurrent ovarian cancer:how important is it to treat to disease progression? Clin Cancer Res. 10, 7439-7449
17. Kelland, L.R. (2005). Emerging drugs for ovarian cancer. Expert Opin Emerging Drugs. 10, 413-424
18. Kim, C.K., Lee, M.K., Han, J.H., Lee, B.J. (1994). Pharmacokinetics and tissue distribution of methotrexate after intravenous injection of differently charged liposomes-encapsulated methotrexate to rats. Int J Pharm. 108, 21-29.
19. Martin F.J. (1998). Clinical pharmacology and antituor efficacy of DOXIL (pegylated liposomal doxorubicin). Medical applications of liposomes. New York: Elsevier Science BV, 635-688
20. Massing, U., Fuxius, S. (2000). Liposomal formulation of anticancer drugs: selectivity and effectiveness. Drug Resist Updates. 3, 171-177
21. Mayou, S.C., Chu, A.C., Munro, D.D., Plowman, N. (1991). Langerhans' cell histiocytosis-an excellent response to etoposide. Clin Exp Dermatol. 16: 292-294
22. Palatini P. (1992). Disposition kinetics of phospholipid liposomes. Neurobiology of essential fatty acids. New York: Plenum Press, 375-391
23. Pardue R.L., White C.A. (1997). Pharmacokinetic evaluation of liposomal encapsulated ampicillin in male and female rats. Biopharm Drug Dispos. 18, 279-292
24. Saita, T., Fujiwara, K., Kitagawa, T., Mori, M., Takata, K. (1990). A highly sensitive enzyme-linked immunosorbent assay for etoposide using β-D-galactosidase as a label. Cancer Chemo Pharmacol. 27, 115-120
25. Sengupta S., Tyagi, P., Velapandian, T., Gupta, Y.K., Gupta, S.K. (2000). Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies. Pharmacol Res. 42, 459-464
26. Senior, J.H. (1987). Fate and behavior of liposomes in vivo: a review of controlling factors. Crit Rev Ther Drug Carrier Syst. 3, 128-193
27. Sinkule, A. (1984). Etoposide: a semisynthetic epipodophyllotoxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent. Pharmacotherapy. 4, 61-73.
28. Viana, M.B., Oliveira, B.M., Silva, C.M., Rios-Leite, V.H. (1991). Etoposide in the treatment for six children with Langerhans' cell histiocytosis (histiocytosis X). Med Pediat Oncol. 19, 289-294
29. Wood, L., Jacobs, P. (1988). Durable response to etoposide-loaded platelets in refractory immune thrombocytopenic purpura: case report. Am J Hematol. 27, 63-64
30. Wozniak, A.J., Ross, W.E. (1983). DNA damage as a basis for 4'-demethyl epipodophyllotoxin-9-(4, 6-O-ethylidene-β-Dglucopyranoside) (etoposide) cytotoxicity. Cancer Res. 43, 120-124
31. Yu, L.C., Shenoy, S., Ward, K., Warrier, R.P. (1994). Successful treatment of multisytem Langerhans' cell histiocytosis (histiocytosis X) with etoposide. Am J Pediat Hematol Oncol. 16, 275-277